Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 5 IN PLASTIC CONTAINER versus OSMITROL 15 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 5 IN PLASTIC CONTAINER versus OSMITROL 15 IN WATER.
MANNITOL 5% IN PLASTIC CONTAINER vs OSMITROL 15% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases the osmolarity of the glomerular filtrate, reducing tubular reabsorption of water and solutes. It also draws water from intracellular spaces into the extracellular fluid, reducing cerebral edema and intraocular pressure.
Osmotic diuretic; increases plasma osmolality, drawing water from extravascular to intravascular space, thereby reducing intracranial and intraocular pressure.
50-100 g intravenously over 30-60 minutes for initial dose in acute renal failure or cerebral edema; maintenance dose 25-50 g every 6-8 hours based on serum osmolality and urine output.
IV infusion of 50-200 g over 30-60 minutes as a 15% solution; typical adult dose is 1.5-2 g/kg every 6-8 hours.
None Documented
None Documented
Terminal elimination half-life: 1–2 hours (adults with normal renal function); prolonged to 24–48 hours in severe renal impairment.
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function; prolonged to 24–36 hours in anuria or severe renal impairment.
Renal: >90% as unchanged drug via glomerular filtration; negligible biliary or fecal elimination.
Primarily renal excretion as unchanged drug; >97% eliminated by glomerular filtration within 24 hours. Minimal biliary/fecal elimination (<3%).
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic